The company intimated a scheduled group meeting with investors, as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The event is a physical group meeting scheduled for October 15, 2026. The location is Dahej, Gujarat. The specific time was not disclosed.
The stated purpose is a meeting with investor(s). The disclosure does not specify if it relates to earnings, a strategic update, or another specific purpose.
The disclosure does not mention if the meeting is scheduled before or after an earnings announcement.
Management participants and their designations were not provided in the intimation.
The company stated that relevant Press Releases and Investor Presentations proposed to be discussed are available on the company's website (www.fermentabiotech.com) and stock exchange websites. It did not specify if a new presentation, transcript, or recording would be made available post-meeting.
The company explicitly confirmed that no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.
Additional Notes Section
The disclosure is a formal regulatory intimation letter addressed to BSE Limited and the National Stock Exchange of India Limited. No attachments were mentioned as being included with this specific filing.
No financial data, guidance references, or presentation summaries were included in this announcement.
The letter includes a note that changes to the meeting may occur due to exigencies on the part of the company or the investors.
